David Logue sees the industry adapting to address medical needs and deliver treatments to patients in ways that afford greater personal empowerment.
David Logue
Advertisement
David Logue is a managing director in Accenture's Life Sciences practice, based in London, UK.
Articles by David Logue
By the end of 2020, it is predicted that AI will create more jobs than it is taking. Should reps be concerned, asks David Logue.
Advertisement
Latest Updated Articles
Will AI Kill Pharma Rep Jobs?August 5th 2019
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5